$XLO Cashflow Statement | Understand Stock

$XLO

$7.31 -$0.26 (3.43%) Close

$XLO Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Non-cash interest (income) expense
Stock-based compensation expense
Change in fair value of common stock warrant liabilities
Issuance costs allocated to common stock warrant liabilities
Loss on disposal of property and equipment
Change in fair value of warrant and derivative liabilities
Changes in operating assets and liabilities:
Collaboration and license agreement receivable
Prepaid and other assets
Operating lease right-of-use asset
Accounts payable
Accrued expenses and other liabilities
Deferred revenue
Operating lease liability
Net cash used in operating activities

Cash flows from investing activities:
Purchases of property and equipment
Net cash used in investing activities
Cash flows from financing activities:
Proceeds from issuance of common stock
At-The-Market Offerings
Exercise of Prefunded Warrants
Total proceeds from issuance of common stock
Proceeds from issuance of prefunded warrants and common stock warrants in connection with a follow-on offering, net of issuance costs
Proceeds from the issuance of common stock, prefunded warrants and liabilities to issue common stock in connection with the exercise of Series B warrants, net of issuance costs
Proceeds from issuance of common stock under employee stock purchase plan
Proceeds from exercise of stock options
Proceeds from issuance of common stock and prefunded warrants in connection with the stock purchase agreement/private placement, net of issuance costs
Gilead Stock Purchase Agreement
Private Placement
Proceeds from issuance of common stock in connection with at-the-market offering
Repayments of debt principal
Proceeds from debt issuance, net of issuance costs
Payments of finance lease
Payments of success fee
Proceeds from issuance of convertible preferred stock, net of issuance costs
Net cash provided by financing activities

Increase in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash, beginning of period
Cash, cash equivalents and restricted cash, end of period
Supplemental cash flow disclosure:
Cash paid for interest
Supplemental disclosure of non-cash activities:
Conversion of convertible preferred stock into common stock upon initial public offering
Transfer of finance lease asset to property and equipment
Capital expenditures included in accounts payable or accrued expenses
Recognition of derivative liability in connection with long-term debt facility
Conversion of warrant liability to equity upon initial public offering
Issuance costs included in accounts payable or accrued expenses

Reconciliation to amounts within the consolidated balance sheets:
Cash and cash equivalents
Restricted cash

Comments